Related Experiment Video

Updated: Jul 5, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

M Sørensen¹, E Felip,

¹Department of Oncology, The Finsen Centre, Rigshospitalet, Copenhagen, Denmark.

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|May 9, 2008

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small-cell lung cancer: 7-year update from the phase III CROWN study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026

Sacral neuromodulation with ultra-low stimulation intensity is effective in faecal incontinence - results from a randomised study with a one-stage implant procedure.

Techniques in coloproctology·2025

Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors.

ESMO open·2025

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

ESMO open·2025

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.

ESMO open·2025

See all related articles